Jacques Essinger und Ceo - Info zur Person

(1 - 21 von 28

)

IsoTis Further Reinforces US Operations

www.finanznachrichten.de

LAUSANNE, Switzerland, and IRVINE, California, July 1 /PRNewswire Pieter Wolters appointed CEO to succeed Jacques Essinger After two consecutive quarters...

Polares Medical Closes a $25M Financing to Enter Clinical Validation

www.b3cnewswire.com

... to clinical evaluation, and to unleash its potential as a game-changer in MR treatment.” said Jacques Essinger, Ph.D, Chairman and CEO. Missing: Agentur ‎Rauhen ‎Hauses"

Polares Medical closes a $25M financing round Startupticker ...www.startupticker.ch › news › july-2018

www.startupticker.ch

said Jacques Essinger, Ph.D, Chairman and CEO. Polares is a preclinical stage spinoff company of Symetis AG, focused on the development of ... Missing: Agentur ‎Rauhen ‎Hauses"

Symetis Acurate TAVI system wins CE mark - NS Medical Devices

www.nsmedicaldevices.com

· Symetis CEO Jacques Essinger said while they will now expand their clinical experience through commercialization of their Acurate TA maintaining the ...

LinkedIn: Jacques Essinger - Schweiz | LinkedIn

Jacques Essinger. CEO at Symetis Location Geneva Area, Switzerland Industry Krankenhaus & Gesundheitsbereich

LinkedIn: Jacques Essinger - CEO & Chairman - POLARES MEDICAL LinkedIn

Lausanne en omgeving, Zwitserland - ‎CEO & Chairman - ‎POLARES MEDICAL SA#####Bekijk het profiel van Jacques Essinger op LinkedIn, de grootste professionele community ter wereld. Jacques Essinger heeft 13 banen functies op zijn of haar ...

Biographie von Jacques Essinger - The Official Board

www.theofficialboard.de

Jacques Essinger ist derzeit Director bei Nuvaira und Director bei V-Wave. Bei V-Wave hat Jacques Essinger 17 Kollegen einschließlich Neal Eigler (CEO), Frank Litvack (Chairman of the Board), ...

SYMETIS Acurate neo_1000 Patient Final

www.symetis.com

Excellent patient outcomes and ease of use are the hallmarks of ACURATE neo/TF.” “Together with our clinical partners and our growing field force we have been able to reach the patient mark for ACURATE neo TF in half the time it took us for ACURATE TA,” said. Jacques Essinger, CEO of Symetis.

Forschungserfolg für Isotis | Archiv | Finanz und Wirtschaft

www.fuw.ch

Die Lausanner Isotis, die ihr operatives Zentrum seit zwei Übernahmen in den USA hat, trennt sich vom bisherigen CEO Jacques Essinger, der offenbar nicht ...

Jacques Essinger | Endeavour Vision - Operating Partner

endeavourvision.com

Jacques joined Endeavour in and brings more than 30 years of entrepreneurial experience in medical devices ranging from product design, clinical and regulatory validation, scale-up and commercial growth, financing, IPO and trade-sale. He is currently acting CEO of Polares and Endostim. He was CEO of Symetis SA, which he grew from concept ...

Symetis Reaches Key Milestone Patients Yahoo Finance

finance.yahoo.com

... to reach the patient mark for ACURATE neo TF in half the time it took us for ACURATE TA," said Jacques Essinger, CEO of Symetis.

Jacques R. Essinger | Symetis | Switzerland

biography.omicsonline.org

Jacques Essinger was appointed CEO of Symetis in 2004, and the company's turnaround to develop and establish Symetis's ACURATE technology platform. He started...

Angel Day workshop: investing in Life Sciences – 12 March |...

republic-of-innovation.ch

:00-21:30 Pannel of entrepreneurs : Nicolas Durand, Founder at Abionic, Jacques Essinger, Chairman at Symetis, Jean-Pierre Rosat, CEO ...

Boston Scientific Builds On Structural Heart Biz With 435M...

www.meddeviceonline.com

“We are excited to be joining Boston Scientific,” said Jacques Essinger, CEO of Symetis. “We have great respect for the company's legacy and ...

Gut fürs Herz | Unternehmen Schweiz | Finanz und Wirtschaft

www.fuw.ch

Gleichzeitig wird die Unternehmensleitung neu besetzt. Als neuer Chief Executive Officer (CEO) hat Jacques Essinger, bis vor kurzem CEO von ...

Konsolidierung in der Start-up-Szene – Sitz bleibt in der Schweiz –...

www.fuw.ch

Noch im Sommer rechnete Modex-CEO Jacques Essinger damit, im Jahr die Gewinnschwelle zu erreichen. Davon kann heute ...

SOPJH® | Le Salon Online Professionnel des Sous-Traitants de...

www.sopjh.ch

... à 5 milliards en dans le monde, a expliqué mercredi Jacques Essinger, CEO de l'entreprise jusqu'à sa vente à Boston Scientific.

Polares Medical raises $25m

www.massdevice.com

... clinical evaluation, and to unleash its potential as a game-changer in MR treatment,” chair & CEO Jacques Essinger said in a press release.

Symetis acquires mitral valve maker Middle Peak Medical

www.massdevice.com

... built-up over the past 10 years for our Acurate product range in the TAVI segment,” Symetis CEO Jacques Essinger said in prepared remarks.

TAVI: Symetis battles the big dogs

www.massdevice.com

... has taken 25% of the EU TA market with our Acurate TA and is the 2nd player after Edwards," CEO Jacques Essinger told MassDevice.com.

Vincent Gardes is Appointed as CEO of Vexim | BioSpace

www.biospace.com

Vincent Gardes is Appointed as CEO of Vexim - read this article along with other careers information, tips and advice on BioSpace

Alle Infos zum Namen "Jacques Essinger"

Verwandte Suchanfragen zu Jacques Essinger

Person "Essinger" (1)
Vorname "Jacques" (3118)
Name "Essinger" (86)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Jacques Essinger und Ceo Person-Info